Cartessa Aesthetics
- Industry
- Medical Devices
- Founded Year
- 2017
- Headquarters
- 175 Broadhollow Road, Melville, NY 11747, United States
- Employee Count
- 337
Key People
- Gabe Lubin - Founder and CEO
- Chris Aronson - Chief Commercial Officer
- A. Storrs - Chief Operating Officer & President
- Jonathan Banks - Chief Financial Officer
- Jill Later - Chief Marketing Officer
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with a track record in the MedTech industry.
The presence of multiple successful MedTech entrepreneurs in the leadership team enhances the company's strategic direction and operational execution.
- Clinical Need
-
Aspect: Very Strong
Summary: The demand for aesthetic medical devices is robust, driven by increasing consumer interest in non-invasive procedures.
The aesthetic devices market is experiencing significant growth, indicating a strong clinical need for innovative solutions.
- Competition
-
Aspect: Very crowded + Strategics
Summary: The market is highly competitive with numerous players, including large strategic companies.
The presence of numerous competitors, including well-established strategic companies, poses challenges for market penetration and differentiation.
- Technical Challenge
-
Aspect: Predictable
Summary: The technical challenges associated with aesthetic devices are well-understood and manageable.
The development and distribution of aesthetic devices involve predictable technical challenges, facilitating efficient product development and deployment.
- Patent
-
Aspect: Strong
Summary: The company holds strong patents that provide a competitive edge.
Strong patent protection enhances the company's market position by safeguarding its innovations from competitors.
- Financing
-
Aspect: Well-funded
Summary: The company has secured substantial funding to support its growth initiatives.
Significant funding from reputable investors enables the company to invest in product development, marketing, and expansion efforts.
- Regulatory
-
Aspect: 510k/PMA
Summary: The company's products have obtained necessary regulatory approvals, facilitating market entry.
Achieving regulatory approvals such as 510(k) or PMA is crucial for market access and demonstrates product safety and efficacy.
Opportunity Rollup
- Odds of Success
- 3.3
- Peak Market Share
- 3.9
- Segment CAGR
- 6.3%
- Market Segment
- Aesthetic Devices
- Market Sub Segment
- Non-invasive Procedures
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.20 |
| 2 | 0.58 |
| 3 | 1.36 |
| 4 | 2.73 |
| 5 | 3.90 |
Key Takeaway
Cartessa Aesthetics, with its experienced leadership and strong market demand, is well-positioned for growth in the competitive aesthetic devices market.